Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
3 hedge funds and large institutions have $62.8K invested in Lexaria Bioscience Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
49% less capital invested
Capital invested by funds: $123K → $62.8K (-$60.6K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$95 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$94 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$98.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$5.96K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $62.5K | – | – | – |
|
|
CS
2
Clear Street
New York
| $150 | +$95 | +100 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $149 | +$94 | +99 | New |
|
|
BFM
4
Boothbay Fund Management
New York
| – | -$98.7K | -78,950 | Closed |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$5.96K | -13,241 | Closed |
|
LEXXW Hedge Fund Activity: Q1 2024 in Review
3 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q1 2024, worth a combined $62.8K — down 49% from $123K a quarter earlier.
Fund positioning in LEXXW was balanced in Q1 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $95. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $98.7K sold.
- 3 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $62.8K of Lexaria Bioscience Warrant stock for Q1 2024, down 49% quarter-over-quarter.
- 2 funds opened new Lexaria Bioscience Warrant positions in Q1 2024 and 2 closed out, a net change of 0 holders.
- The largest Lexaria Bioscience Warrant buyer in Q1 2024 was Clear Street, an estimated $95 added.
- The largest Lexaria Bioscience Warrant seller in Q1 2024 was Boothbay Fund Management, an estimated $98.7K sold.
Based on aggregated 13F filings for Q1 2024.